Education
About Us
Working with TipRanks
Follow Us
Spruce Biosciences, Inc. (SPRB)
:SPRB
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.09M | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -39.34M | $ -429.00K | $ -381.00K | $ -102.00K | $ -12.00K |
| Operating Income | $ -51.99M | $ -47.28M | $ -42.07M | $ -29.42M | $ -13.11M |
| EBITDA | $ -47.37M | $ -45.33M | $ -41.57M | $ -29.11M | $ -13.10M |
| Net Income | $ -47.92M | $ -45.08M | $ -42.69M | $ -30.03M | $ -13.24M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 96.34M | $ 79.08M | $ 88.97M | $ 157.15M | $ 3.92M |
| Total Assets | $ 103.95M | $ 85.65M | $ 126.49M | $ 162.88M | $ 4.69M |
| Total Debt | $ 4.61M | $ 6.18M | $ 6.17M | $ 6.13M | $ 4.45M |
| Net Debt | $ -91.73M | $ -18.31M | $ -36.58M | $ -151.02M | $ 521.00K |
| Total Liabilities | $ 27.44M | $ 17.16M | $ 15.12M | $ 13.46M | $ 35.33M |
| Stockholders' Equity | $ 76.51M | $ 68.49M | $ 111.37M | $ 149.43M | $ -30.64M |
| Cash Flow | |||||
| Free Cash Flow | $ -33.28M | $ -41.69M | $ -35.97M | $ -27.59M | $ -12.62M |
| Operating Cash Flow | $ -33.27M | $ -41.68M | $ -35.88M | $ -27.52M | $ -12.62M |
| Investing Cash Flow | $ 55.78M | $ 23.69M | $ -79.17M | $ -74.00K | $ -4.00K |
| Financing Cash Flow | $ 49.14M | $ -241.00K | $ 643.00K | $ 181.03M | $ 12.43M |